Commit To Purchase Enanta Pharmaceuticals At $42, Earn 13.5% Annualized Using Options
December 30, 2014 at 13:50 PM EST
Investors considering a purchase of Enanta Pharmaceuticals, Inc. (ENTA) stock, but tentative about paying the going market price of $51.47/share, might benefit from considering selling puts among the alternative strategies at their disposal..